Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-007743
Filing Date
2025-03-14
Accepted
2025-03-14 16:31:05
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nrxp20241231c_10k.htm   iXBRL 10-K 2598771
2 EXHIBIT 19.1 ex_790359.htm EX-19.1 48126
3 EXHIBIT 23.1 ex_789047.htm EX-23.1 2772
4 EXHIBIT 31.1 ex_790360.htm EX-31.1 12391
5 EXHIBIT 31.2 ex_790361.htm EX-31.2 12372
6 EXHIBIT 32.1 ex_790362.htm EX-32.1 5266
7 EXHIBIT 32.2 ex_790363.htm EX-32.2 5114
13 map01.jpg GRAPHIC 32275
14 nrxgraph1.jpg GRAPHIC 40954
15 nrxgraph2.jpg GRAPHIC 26708
16 nrxpic.jpg GRAPHIC 124291
17 nrxtable1.jpg GRAPHIC 47703
18 salberglogo.jpg GRAPHIC 32263
19 totalcareumbrella.jpg GRAPHIC 120235
  Complete submission text file 0001437749-25-007743.txt   12349717

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA nrxp-20241231.xsd EX-101.SCH 86586
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nrxp-20241231_cal.xml EX-101.CAL 51770
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nrxp-20241231_def.xml EX-101.DEF 646461
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrxp-20241231_lab.xml EX-101.LAB 525495
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrxp-20241231_pre.xml EX-101.PRE 680686
95 EXTRACTED XBRL INSTANCE DOCUMENT nrxp20241231c_10k_htm.xml XML 1518779
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

EIN.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38302 | Film No.: 25740503
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)